News Quanterix Corporation

Equities

QTRX

US74766Q1013

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 12:14:36 2026-03-17 pm EDT			5-day change	1st Jan Change
4.650 ^USD	-1.27%		-7.17%	-26.73%

Mar. 02	Quanterix Corporation, Q4 2025 Earnings Call, Mar 02, 2026
Mar. 02	Quanterix Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

All News

Mar. 02	Quanterix Corporation, Q4 2025 Earnings Call, Mar 02, 2026
Mar. 02	Quanterix Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Mar. 02	Quanterix : Q4-25 Earnings Presentation-FINAL	PU
Mar. 02	Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025	BU
Mar. 02	Quanterix Provides Earnings Guidance for the Year 2026	CI
Mar. 02	Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide	BU
Mar. 02	Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide	CI
Feb. 26	Quanterix to Participate in Upcoming Investor Conferences	BU
Feb. 23	Quanterix to Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026	AQ
Feb. 20	Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026	BU
Feb. 03	Quanterix Files 510(k) With FDA for Alzheimer's Blood Test	MT
Feb. 03	Quanterix announces FDA 510(k) submission for a multi-analyte algorithmic blood test for Alzheimer’s disease detection	RE
Feb. 03	Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer’s Disease Detection	BU
Feb. 03	Quanterix Corporation Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer's Disease Detection	CI
Jan. 21	Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer’s Risk Profiling	BU
Jan. 21	Quanterix Corporation Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling	CI
Jan. 19	Quanterix Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	AQ
Jan. 16	Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
Jan. 08	Quanterix Names Everett Cunningham President and CEO	MT
Jan. 08	Quanterix Names Everett Cunningham President and CEO	MT
Jan. 08	Quanterix Corporation Announces Chief Executive Officer Changes, Effective January 19, 2026	CI
Jan. 08	Quanterix Corporation Announces Management Changes, Effective January 19, 2026	CI
Jan. 08	Quanterix appoints Everett Cunningham as president and CEO effective January 19, 2026	RE
Jan. 08	Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026	BU
Dec. 22	Quanterix announces landmark Nature study redefining Alzheimer's disease Neuropathology prevalence	RE